IMMTECH PHARMACEUTICALS, INC. 4
4 · IMMTECH PHARMACEUTICALS, INC. · Filed Jul 7, 2006
Insider Transaction Report
Form 4
WACKERLE FREDERICK W
Director
Transactions
- Conversion
Common Stock, $0.01 par value
2006-07-05+13,690→ 144,679 total - Conversion
Series A Convertible Preferred Stock
2006-07-05$25.00/sh−2,400$60,000→ 106,936 totalExercise: $4.42From: 2002-02-14→ Common Stock, $0.01 par value (13,575 underlying)
Footnotes (3)
- [F1]Includes 37,743 shares of common stock; and derivative securities of (i) 7,102 shares of common stock issuable upon the conversion of series E preferred stock; (ii) 7,250 shares of common stock issuable upon the exercise of warrants as follows: vested warrant to purchase 6,000 shares of common stock at $6.00 per share by February 14, 2007, and vested warrant to purchase 1,250 shares of common stock at $10.00 per share by December 13, 2008; and (iii) 92,584 shares of common stock issuable upon the exercise of options as follows: vested option to purchase 15,000 shares of common stock at $10.50 per share by December 28, 2010, vested option to purchase 22,000 shares of common stock at $4.75 per share by December 18, 2006, vested option to purchase 7,000 shares of common stock at $2.55 per share by December 24, 2007, (footnote to be continued)
- [F2]vested option to purchase 22,000 shares of common stock at $14.29 per share by February 1, 2014, the vested portion of 20,167 shares of an option to purchase 22,000 shares of common stock at $11.03 by November 15, 2014, and the vested portion of 6,417 shares of an option to purchase 22,000 shares of common stock at $7.85 by January 24, 2016.
- [F3]Not applicable.